UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
Under the Securities Exchange Act of 1934
()
Moore Medical Corp.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
615799103
(CUSIP Number)
January 22,2004
(Date of Event Which Requires Filing of this Statement)
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 5 Pages
CUSIP No 615799103 13G
--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
TowerView LLC. Employer I.D.# 13-4159490
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) |_|
(b) |X|
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
--------------------------------------------------------------------------------
NUMBER OF 5. SOLE VOTING POWER
SHARES 193,500
-----------------------------------------------------------------
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
-----------------------------------------------------------------
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 193,500
-----------------------------------------------------------------
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
193,500
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|_|
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.0%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 5 Pages
Item 1(a). Name of Issuer:
The name of the issuer is Moore Medical Corp. (the "Issuer").
Item 1(b). Address of Issuer's Principal Executive Offices:
The Issuer's principal executive offices are located at P.O. Box
1500 New Britain, CT 06050
Item 2(a). Name of Person Filing:
This report is being filed by TowerView LLC (the "Reporting
Person").
Item 2(b). Address of Principal Business Office or, if None, Residence:
The Reporting Person's principal business address is 500 Park
Avenue, New York, New York 10022.
Item 2(c). Citizenship:
The Reporting Person is a Limited Liability Company organized under
the laws of Delaware.
Item 2(d). Title of Class of Securities:
The report covers the Issuer's Common Stock (the "Shares"), $.01
value.
Item 2(e). CUSIP Number:
The CUSIP number of the Shares is 615799103.
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a:
(a) |_| Broker and dealer registered under Section 15 of the
Exchange Act.
(b) |_| Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) |_| Insurance company as defined in Section 3(a)(19) of the
Exchange Act.
(d) |_| Investment company registered under Section 8 of the
Investment Company Act.
(e) |_| An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);
(h) |_| A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act;
(i) |_| A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the
Investment Company Act;
(j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Page 3 of 5 Pages
If this statement is filed pursuant to Rule 13d-1(c), check this
box. |X|
Item 4. Ownership
(a) Amount beneficially owned: As of January 22, 2004 the Reporting
Person beneficially owned 193,500 shares (the "Shares") of Common
Stock.
(b) Percent of class: As of January 20, 2004 the Issuer had
outstanding 3,200,009 shares of Common Stock. The 193,500 shares of
Common Stock held beneficially by the Reporting Person represented
6.0% of the outstanding shares of Common Stock.
(c) Number of Shares as to which the Reporting Person has:
(i) sole power to vote or direct the vote -- 193,500 shares;
(ii) shared power to vote or to direct the vote -- none;
(iii) sole power to dispose or direct the disposition of --
193,500 shares; and
(iv) shared power to dispose or to direct the disposition of
-- none.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following |_|.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
The Security Being Reported on By The Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
Page 4 of 5 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
January 23, 2004
(Date)
/s/ Daniel R. Tisch
------------------------------------
(Signature)
Daniel R. Tisch
Authorized Signatory
TowerView LLC
------------------------------------
(Name/Title)
Page 5 of 5 Pages